The Substance Use Research Priority Area has set the date for its sixth annual Substance Use Research Event (SURE) and registration is currently open.

A team of researchers at the University of Kentucky is working to better understand the impact of opioid use disorder on mothers and babies.

The grant, in collaboration with the Kentucky Department for Public Health, provides opportunities to strengthen ongoing efforts to combat Kentucky’s drug overdose crisis and reduce overdose-related harms.

The $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) will support research to understand how xylazine and fentanyl change the brain’s signaling pathways.

Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.

The University of Kentucky has been selected as the nationwide coordination center for a National Institutes of Health (NIH) initiative, supported by a $3.4 million, five-year grant.

Aug. 31 marks International Overdose Awareness Day, a time when attention is directed toward raising awareness about opioid overdose and ways to reverse deadly effects. One such way is naloxone, which has become more available throughout Kentucky due to UK’s HEALing Communities Study.

William Stoops, Ph.D., a professor in the UK College of Medicine’s Department of Behavioral Science, Psychiatry and Psychology, is one of 16 University Research Professors for 2023-24.

The Foundation for Opioid Response Efforts (FORE) has selected the University of Kentucky College of Pharmacy as one of three higher education entities funded to improve access to medications for opioid use disorder in pharmacies and health care settings.